We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abilify Tardive Dyskinesia Suit Dismissed Because Label Warns Of Risk, Judge Says

(July 9, 2018, 12:00 PM EDT) -- BLUEFIELD, W. Va. — A West Virginia federal judge on July 5 granted judgment for the distributors of Abilify, finding that the drug’s label explicitly warned about the risk of tardive...
To view the full article, register now.